Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Small Molecule Libraries | 5 | 2021 | 720 | 1.680 |
Why?
|
| Zinc | 3 | 2022 | 684 | 1.180 |
Why?
|
| Proline | 5 | 2016 | 458 | 1.000 |
Why?
|
| Proteins | 8 | 2023 | 6103 | 0.850 |
Why?
|
| Esters | 2 | 2013 | 210 | 0.800 |
Why?
|
| Silicon | 1 | 2022 | 145 | 0.800 |
Why?
|
| Models, Chemical | 3 | 2016 | 626 | 0.760 |
Why?
|
| Insulin-Secreting Cells | 6 | 2023 | 891 | 0.760 |
Why?
|
| Optical Phenomena | 1 | 2020 | 107 | 0.730 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2024 | 1861 | 0.720 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2022 | 434 | 0.720 |
Why?
|
| Electrons | 5 | 2014 | 268 | 0.710 |
Why?
|
| Glucagon-Secreting Cells | 2 | 2023 | 41 | 0.700 |
Why?
|
| Thalidomide | 2 | 2024 | 890 | 0.690 |
Why?
|
| Synthetic Biology | 1 | 2020 | 179 | 0.630 |
Why?
|
| Ubiquitin | 1 | 2023 | 852 | 0.630 |
Why?
|
| Inheritance Patterns | 1 | 2020 | 340 | 0.630 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2022 | 689 | 0.590 |
Why?
|
| Bacteriophages | 1 | 2020 | 356 | 0.590 |
Why?
|
| Alkenes | 2 | 2016 | 57 | 0.550 |
Why?
|
| Stereoisomerism | 5 | 2014 | 624 | 0.530 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2023 | 1990 | 0.520 |
Why?
|
| Peptides | 5 | 2016 | 4409 | 0.460 |
Why?
|
| High-Throughput Screening Assays | 1 | 2019 | 944 | 0.450 |
Why?
|
| Genetic Engineering | 1 | 2019 | 951 | 0.440 |
Why?
|
| Molecular Structure | 6 | 2021 | 1899 | 0.430 |
Why?
|
| Chromogenic Compounds | 1 | 2011 | 30 | 0.420 |
Why?
|
| Molecular Conformation | 6 | 2014 | 563 | 0.420 |
Why?
|
| Thioamides | 1 | 2011 | 1 | 0.410 |
Why?
|
| Carbohydrate Biochemistry | 1 | 2011 | 1 | 0.410 |
Why?
|
| Amides | 3 | 2012 | 459 | 0.390 |
Why?
|
| Drosophila melanogaster | 1 | 2020 | 1708 | 0.390 |
Why?
|
| B-Lymphocytes | 2 | 2022 | 4665 | 0.370 |
Why?
|
| Quantum Theory | 1 | 2010 | 70 | 0.360 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2011 | 474 | 0.340 |
Why?
|
| Models, Molecular | 10 | 2013 | 5456 | 0.340 |
Why?
|
| Crystallography, X-Ray | 7 | 2019 | 2011 | 0.340 |
Why?
|
| Luminescent Proteins | 1 | 2011 | 853 | 0.330 |
Why?
|
| Oxides | 1 | 2010 | 405 | 0.320 |
Why?
|
| Conserved Sequence | 1 | 2011 | 1202 | 0.320 |
Why?
|
| Nucleic Acids | 1 | 2010 | 182 | 0.310 |
Why?
|
| Nucleotides | 1 | 2010 | 464 | 0.300 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2020 | 3336 | 0.300 |
Why?
|
| Hydrogen Bonding | 3 | 2011 | 293 | 0.290 |
Why?
|
| Genomics | 1 | 2022 | 5720 | 0.280 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2023 | 11725 | 0.280 |
Why?
|
| RNA | 2 | 2021 | 2749 | 0.280 |
Why?
|
| Phosphorylation | 4 | 2022 | 8436 | 0.250 |
Why?
|
| Hydroxyproline | 2 | 2016 | 116 | 0.240 |
Why?
|
| Protein Conformation | 4 | 2015 | 4011 | 0.230 |
Why?
|
| Imidazolidines | 2 | 2013 | 39 | 0.220 |
Why?
|
| Directed Molecular Evolution | 1 | 2024 | 160 | 0.220 |
Why?
|
| Ionophores | 1 | 2022 | 108 | 0.210 |
Why?
|
| Zinc Fingers | 1 | 2024 | 585 | 0.200 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2023 | 402 | 0.200 |
Why?
|
| Ions | 1 | 2022 | 265 | 0.200 |
Why?
|
| Proteomics | 1 | 2014 | 3638 | 0.190 |
Why?
|
| Chelating Agents | 1 | 2022 | 380 | 0.190 |
Why?
|
| Glycosylation | 1 | 2023 | 1126 | 0.180 |
Why?
|
| Biology | 2 | 2023 | 294 | 0.180 |
Why?
|
| Thermodynamics | 5 | 2012 | 596 | 0.180 |
Why?
|
| Static Electricity | 2 | 2011 | 267 | 0.180 |
Why?
|
| Islets of Langerhans | 2 | 2023 | 1352 | 0.180 |
Why?
|
| Pyrrolidines | 2 | 2012 | 342 | 0.170 |
Why?
|
| Aspirin | 1 | 2011 | 3282 | 0.170 |
Why?
|
| Trimethoprim | 1 | 2019 | 91 | 0.170 |
Why?
|
| Molecular Probes | 1 | 2021 | 316 | 0.170 |
Why?
|
| Insulin Infusion Systems | 1 | 2020 | 212 | 0.170 |
Why?
|
| Prodrugs | 1 | 2020 | 268 | 0.160 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 2019 | 143 | 0.160 |
Why?
|
| Catalysis | 1 | 2020 | 761 | 0.160 |
Why?
|
| Transcription Factors | 2 | 2023 | 12208 | 0.160 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2019 | 195 | 0.150 |
Why?
|
| Substrate Specificity | 2 | 2019 | 1801 | 0.150 |
Why?
|
| Computer Simulation | 2 | 2010 | 6196 | 0.150 |
Why?
|
| Metals | 1 | 2022 | 719 | 0.150 |
Why?
|
| Protein Kinase C | 1 | 2022 | 1227 | 0.150 |
Why?
|
| Streptococcus pyogenes | 1 | 2019 | 289 | 0.140 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2016 | 86 | 0.140 |
Why?
|
| Mammals | 1 | 2022 | 1143 | 0.140 |
Why?
|
| Genome, Viral | 1 | 2020 | 667 | 0.140 |
Why?
|
| Endonucleases | 1 | 2019 | 380 | 0.140 |
Why?
|
| Isomerism | 2 | 2016 | 201 | 0.140 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2021 | 1375 | 0.130 |
Why?
|
| INDEL Mutation | 1 | 2016 | 279 | 0.130 |
Why?
|
| Protein Engineering | 1 | 2019 | 540 | 0.130 |
Why?
|
| Animals, Genetically Modified | 1 | 2020 | 1549 | 0.130 |
Why?
|
| Cell Line | 3 | 2020 | 15997 | 0.120 |
Why?
|
| Neurodegenerative Diseases | 1 | 2023 | 1061 | 0.120 |
Why?
|
| Immune System | 1 | 2020 | 805 | 0.120 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2014 | 31 | 0.120 |
Why?
|
| Protective Agents | 1 | 2015 | 156 | 0.120 |
Why?
|
| Ultraviolet Rays | 1 | 2019 | 1060 | 0.120 |
Why?
|
| STAT1 Transcription Factor | 1 | 2015 | 320 | 0.120 |
Why?
|
| Catalytic Domain | 2 | 2016 | 698 | 0.120 |
Why?
|
| Molecular Imaging | 1 | 2021 | 828 | 0.120 |
Why?
|
| Protein Structure, Secondary | 3 | 2011 | 1246 | 0.110 |
Why?
|
| Halogens | 1 | 2012 | 13 | 0.110 |
Why?
|
| Hydrocarbons, Halogenated | 1 | 2012 | 20 | 0.110 |
Why?
|
| Ketones | 1 | 2014 | 188 | 0.110 |
Why?
|
| Drug Discovery | 1 | 2021 | 1058 | 0.110 |
Why?
|
| Transcriptional Activation | 1 | 2019 | 1783 | 0.110 |
Why?
|
| Light | 1 | 2019 | 1374 | 0.110 |
Why?
|
| Protein Stability | 2 | 2011 | 557 | 0.110 |
Why?
|
| Janus Kinase 2 | 1 | 2015 | 528 | 0.100 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 1071 | 0.100 |
Why?
|
| Physical Phenomena | 1 | 2011 | 46 | 0.100 |
Why?
|
| Protein Structure, Tertiary | 1 | 2019 | 3846 | 0.100 |
Why?
|
| DNA | 2 | 2019 | 7301 | 0.100 |
Why?
|
| Evolution, Chemical | 1 | 2010 | 3 | 0.100 |
Why?
|
| Fluorides | 1 | 2011 | 127 | 0.090 |
Why?
|
| Genome | 1 | 2019 | 1808 | 0.090 |
Why?
|
| Molecular Mimicry | 1 | 2011 | 201 | 0.090 |
Why?
|
| Hexanes | 1 | 2009 | 7 | 0.090 |
Why?
|
| Humans | 19 | 2024 | 744343 | 0.090 |
Why?
|
| Binding Sites | 1 | 2019 | 6114 | 0.090 |
Why?
|
| Azabicyclo Compounds | 1 | 2009 | 68 | 0.090 |
Why?
|
| Amino Acid Sequence | 2 | 2011 | 13815 | 0.090 |
Why?
|
| Fluorescence | 1 | 2011 | 751 | 0.080 |
Why?
|
| RNA Precursors | 1 | 2010 | 208 | 0.080 |
Why?
|
| Recombinant Proteins | 1 | 2019 | 6622 | 0.080 |
Why?
|
| Collagen | 2 | 2015 | 2689 | 0.080 |
Why?
|
| Nuclear Proteins | 1 | 2023 | 5853 | 0.080 |
Why?
|
| Oxidation-Reduction | 1 | 2013 | 2187 | 0.080 |
Why?
|
| Protein Folding | 1 | 2011 | 843 | 0.080 |
Why?
|
| HEK293 Cells | 1 | 2016 | 4204 | 0.070 |
Why?
|
| Animals | 7 | 2023 | 168757 | 0.070 |
Why?
|
| Nucleic Acid Conformation | 1 | 2010 | 913 | 0.070 |
Why?
|
| Interferon-gamma | 1 | 2015 | 3206 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 1 | 2011 | 2088 | 0.070 |
Why?
|
| Ubiquitination | 2 | 2024 | 1012 | 0.070 |
Why?
|
| Protein Binding | 2 | 2016 | 9386 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2014 | 2915 | 0.060 |
Why?
|
| Fluoresceins | 1 | 2023 | 235 | 0.060 |
Why?
|
| Pancreatic Elastase | 1 | 2023 | 136 | 0.060 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2010 | 3760 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 16689 | 0.050 |
Why?
|
| Transcription, Genetic | 1 | 2016 | 7722 | 0.050 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2023 | 443 | 0.050 |
Why?
|
| Hypoglycemic Agents | 1 | 2014 | 2872 | 0.050 |
Why?
|
| Glucagon | 1 | 2023 | 533 | 0.050 |
Why?
|
| Cryoelectron Microscopy | 1 | 2024 | 571 | 0.050 |
Why?
|
| Cells, Cultured | 1 | 2016 | 19229 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 12072 | 0.050 |
Why?
|
| Insulin | 2 | 2023 | 6580 | 0.040 |
Why?
|
| Hydroxylation | 1 | 2016 | 141 | 0.040 |
Why?
|
| Chlamydomonas reinhardtii | 1 | 2016 | 33 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2021 | 2505 | 0.040 |
Why?
|
| Mice | 3 | 2023 | 81183 | 0.030 |
Why?
|
| Cell Communication | 1 | 2023 | 1621 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2021 | 3129 | 0.030 |
Why?
|
| Models, Biological | 1 | 2011 | 9583 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2023 | 1809 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2023 | 2969 | 0.030 |
Why?
|
| Protein Carbonylation | 1 | 2012 | 29 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2020 | 1678 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 2021 | 1917 | 0.030 |
Why?
|
| Species Specificity | 1 | 2016 | 2478 | 0.030 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2015 | 449 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2023 | 3462 | 0.030 |
Why?
|
| Glucose | 1 | 2023 | 4397 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2021 | 5974 | 0.020 |
Why?
|
| Databases, Nucleic Acid | 1 | 2010 | 211 | 0.020 |
Why?
|
| Kinetics | 1 | 2016 | 6473 | 0.020 |
Why?
|
| Drug Design | 1 | 2014 | 1076 | 0.020 |
Why?
|
| Dipeptides | 1 | 2010 | 409 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2023 | 23403 | 0.020 |
Why?
|
| Cell Survival | 1 | 2015 | 5882 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2020 | 10481 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 2727 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2009 | 2203 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2014 | 6256 | 0.010 |
Why?
|
| Apoptosis | 1 | 2015 | 9727 | 0.010 |
Why?
|
| Rats | 1 | 2015 | 24260 | 0.010 |
Why?
|
| Computational Biology | 1 | 2010 | 3521 | 0.010 |
Why?
|
Concepts
(175)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(24)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_